Medical Care

Global Mental Disorder Treatment Market Research Report 2024

A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.
These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.
The global Mental Disorder Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mental Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorder Treatment.
Report Scope
The Mental Disorder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mental Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc
Eli Lilly and Company
VistaGen Therapeutics
Sanofi S.A
Novartis International AG
Mylan N.V
Amneal Pharmaceuticals LLC
Cipla Ltd
Sun Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Limited
Lupin Limited
Janssen Pharmaceutica
Bristol Myers Squibb
Sumitomo Dainippon Pharma Co., Ltd
Segment by Type
Medications
Self-help Therapies
Segment by Application
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mental Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mental Disorder Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medications
1.2.3 Self-help Therapies
1.3 Market by Application
1.3.1 Global Mental Disorder Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Depression
1.3.3 Bipolar Disorder
1.3.4 Schizophrenia
1.3.5 Dementia
1.3.6 Post-traumatic Stress Disorder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mental Disorder Treatment Market Perspective (2019-2030)
2.2 Mental Disorder Treatment Growth Trends by Region
2.2.1 Global Mental Disorder Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mental Disorder Treatment Historic Market Size by Region (2019-2024)
2.2.3 Mental Disorder Treatment Forecasted Market Size by Region (2025-2030)
2.3 Mental Disorder Treatment Market Dynamics
2.3.1 Mental Disorder Treatment Industry Trends
2.3.2 Mental Disorder Treatment Market Drivers
2.3.3 Mental Disorder Treatment Market Challenges
2.3.4 Mental Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mental Disorder Treatment Players by Revenue
3.1.1 Global Top Mental Disorder Treatment Players by Revenue (2019-2024)
3.1.2 Global Mental Disorder Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mental Disorder Treatment Revenue
3.4 Global Mental Disorder Treatment Market Concentration Ratio
3.4.1 Global Mental Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mental Disorder Treatment Revenue in 2023
3.5 Mental Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Mental Disorder Treatment Product Solution and Service
3.7 Date of Enter into Mental Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mental Disorder Treatment Breakdown Data by Type
4.1 Global Mental Disorder Treatment Historic Market Size by Type (2019-2024)
4.2 Global Mental Disorder Treatment Forecasted Market Size by Type (2025-2030)
5 Mental Disorder Treatment Breakdown Data by Application
5.1 Global Mental Disorder Treatment Historic Market Size by Application (2019-2024)
5.2 Global Mental Disorder Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mental Disorder Treatment Market Size (2019-2030)
6.2 North America Mental Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mental Disorder Treatment Market Size by Country (2019-2024)
6.4 North America Mental Disorder Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mental Disorder Treatment Market Size (2019-2030)
7.2 Europe Mental Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mental Disorder Treatment Market Size by Country (2019-2024)
7.4 Europe Mental Disorder Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mental Disorder Treatment Market Size (2019-2030)
8.2 Asia-Pacific Mental Disorder Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mental Disorder Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Mental Disorder Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mental Disorder Treatment Market Size (2019-2030)
9.2 Latin America Mental Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mental Disorder Treatment Market Size by Country (2019-2024)
9.4 Latin America Mental Disorder Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mental Disorder Treatment Market Size (2019-2030)
10.2 Middle East & Africa Mental Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mental Disorder Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Mental Disorder Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Detail
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Mental Disorder Treatment Introduction
11.1.4 Allergan Plc Revenue in Mental Disorder Treatment Business (2019-2024)
11.1.5 Allergan Plc Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Detail
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Mental Disorder Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2019-2024)
11.2.5 Eli Lilly and Company Recent Development
11.3 VistaGen Therapeutics
11.3.1 VistaGen Therapeutics Company Detail
11.3.2 VistaGen Therapeutics Business Overview
11.3.3 VistaGen Therapeutics Mental Disorder Treatment Introduction
11.3.4 VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2019-2024)
11.3.5 VistaGen Therapeutics Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Detail
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Mental Disorder Treatment Introduction
11.4.4 Sanofi S.A Revenue in Mental Disorder Treatment Business (2019-2024)
11.4.5 Sanofi S.A Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Detail
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Mental Disorder Treatment Introduction
11.5.4 Novartis International AG Revenue in Mental Disorder Treatment Business (2019-2024)
11.5.5 Novartis International AG Recent Development
11.6 Mylan N.V
11.6.1 Mylan N.V Company Detail
11.6.2 Mylan N.V Business Overview
11.6.3 Mylan N.V Mental Disorder Treatment Introduction
11.6.4 Mylan N.V Revenue in Mental Disorder Treatment Business (2019-2024)
11.6.5 Mylan N.V Recent Development
11.7 Amneal Pharmaceuticals LLC
11.7.1 Amneal Pharmaceuticals LLC Company Detail
11.7.2 Amneal Pharmaceuticals LLC Business Overview
11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Introduction
11.7.4 Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2019-2024)
11.7.5 Amneal Pharmaceuticals LLC Recent Development
11.8 Cipla Ltd
11.8.1 Cipla Ltd Company Detail
11.8.2 Cipla Ltd Business Overview
11.8.3 Cipla Ltd Mental Disorder Treatment Introduction
11.8.4 Cipla Ltd Revenue in Mental Disorder Treatment Business (2019-2024)
11.8.5 Cipla Ltd Recent Development
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Sun Pharmaceutical Industries Ltd Company Detail
11.9.2 Sun Pharmaceutical Industries Ltd Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Introduction
11.9.4 Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2019-2024)
11.9.5 Sun Pharmaceutical Industries Ltd Recent Development
11.10 Glenmark Pharmaceuticals Limited
11.10.1 Glenmark Pharmaceuticals Limited Company Detail
11.10.2 Glenmark Pharmaceuticals Limited Business Overview
11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Introduction
11.10.4 Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2019-2024)
11.10.5 Glenmark Pharmaceuticals Limited Recent Development
11.11 Lupin Limited
11.11.1 Lupin Limited Company Detail
11.11.2 Lupin Limited Business Overview
11.11.3 Lupin Limited Mental Disorder Treatment Introduction
11.11.4 Lupin Limited Revenue in Mental Disorder Treatment Business (2019-2024)
11.11.5 Lupin Limited Recent Development
11.12 Janssen Pharmaceutica
11.12.1 Janssen Pharmaceutica Company Detail
11.12.2 Janssen Pharmaceutica Business Overview
11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Introduction
11.12.4 Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2019-2024)
11.12.5 Janssen Pharmaceutica Recent Development
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Company Detail
11.13.2 Bristol Myers Squibb Business Overview
11.13.3 Bristol Myers Squibb Mental Disorder Treatment Introduction
11.13.4 Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2019-2024)
11.13.5 Bristol Myers Squibb Recent Development
11.14 Sumitomo Dainippon Pharma Co., Ltd
11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.14.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Introduction
11.14.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2019-2024)
11.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Mental Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medications
Table 3. Key Players of Self-help Therapies
Table 4. Global Mental Disorder Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Mental Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Mental Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Mental Disorder Treatment Market Share by Region (2019-2024)
Table 8. Global Mental Disorder Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Mental Disorder Treatment Market Share by Region (2025-2030)
Table 10. Mental Disorder Treatment Market Trends
Table 11. Mental Disorder Treatment Market Drivers
Table 12. Mental Disorder Treatment Market Challenges
Table 13. Mental Disorder Treatment Market Restraints
Table 14. Global Mental Disorder Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Mental Disorder Treatment Market Share by Players (2019-2024)
Table 16. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2023)
Table 17. Ranking of Global Top Mental Disorder Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Mental Disorder Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mental Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Mental Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mental Disorder Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Mental Disorder Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Mental Disorder Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Mental Disorder Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Mental Disorder Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Mental Disorder Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Mental Disorder Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Mental Disorder Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Mental Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Mental Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Mental Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Mental Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Mental Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Mental Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Mental Disorder Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Mental Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Mental Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Mental Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Mental Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Allergan Plc Company Detail
Table 47. Allergan Plc Business Overview
Table 48. Allergan Plc Mental Disorder Treatment Product
Table 49. Allergan Plc Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 50. Allergan Plc Recent Development
Table 51. Eli Lilly and Company Company Detail
Table 52. Eli Lilly and Company Business Overview
Table 53. Eli Lilly and Company Mental Disorder Treatment Product
Table 54. Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 55. Eli Lilly and Company Recent Development
Table 56. VistaGen Therapeutics Company Detail
Table 57. VistaGen Therapeutics Business Overview
Table 58. VistaGen Therapeutics Mental Disorder Treatment Product
Table 59. VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 60. VistaGen Therapeutics Recent Development
Table 61. Sanofi S.A Company Detail
Table 62. Sanofi S.A Business Overview
Table 63. Sanofi S.A Mental Disorder Treatment Product
Table 64. Sanofi S.A Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 65. Sanofi S.A Recent Development
Table 66. Novartis International AG Company Detail
Table 67. Novartis International AG Business Overview
Table 68. Novartis International AG Mental Disorder Treatment Product
Table 69. Novartis International AG Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 70. Novartis International AG Recent Development
Table 71. Mylan N.V Company Detail
Table 72. Mylan N.V Business Overview
Table 73. Mylan N.V Mental Disorder Treatment Product
Table 74. Mylan N.V Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 75. Mylan N.V Recent Development
Table 76. Amneal Pharmaceuticals LLC Company Detail
Table 77. Amneal Pharmaceuticals LLC Business Overview
Table 78. Amneal Pharmaceuticals LLC Mental Disorder Treatment Product
Table 79. Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 80. Amneal Pharmaceuticals LLC Recent Development
Table 81. Cipla Ltd Company Detail
Table 82. Cipla Ltd Business Overview
Table 83. Cipla Ltd Mental Disorder Treatment Product
Table 84. Cipla Ltd Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 85. Cipla Ltd Recent Development
Table 86. Sun Pharmaceutical Industries Ltd Company Detail
Table 87. Sun Pharmaceutical Industries Ltd Business Overview
Table 88. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product
Table 89. Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 90. Sun Pharmaceutical Industries Ltd Recent Development
Table 91. Glenmark Pharmaceuticals Limited Company Detail
Table 92. Glenmark Pharmaceuticals Limited Business Overview
Table 93. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product
Table 94. Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 95. Glenmark Pharmaceuticals Limited Recent Development
Table 96. Lupin Limited Company Detail
Table 97. Lupin Limited Business Overview
Table 98. Lupin Limited Mental Disorder Treatment Product
Table 99. Lupin Limited Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 100. Lupin Limited Recent Development
Table 101. Janssen Pharmaceutica Company Detail
Table 102. Janssen Pharmaceutica Business Overview
Table 103. Janssen Pharmaceutica Mental Disorder Treatment Product
Table 104. Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 105. Janssen Pharmaceutica Recent Development
Table 106. Bristol Myers Squibb Company Detail
Table 107. Bristol Myers Squibb Business Overview
Table 108. Bristol Myers Squibb Mental Disorder Treatment Product
Table 109. Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 110. Bristol Myers Squibb Recent Development
Table 111. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 112. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 113. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product
Table 114. Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2019-2024) & (US$ Million)
Table 115. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mental Disorder Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Mental Disorder Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medications Features
Figure 4. Self-help Therapies Features
Figure 5. Global Mental Disorder Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Mental Disorder Treatment Market Share by Application: 2023 VS 2030
Figure 7. Depression Case Studies
Figure 8. Bipolar Disorder Case Studies
Figure 9. Schizophrenia Case Studies
Figure 10. Dementia Case Studies
Figure 11. Post-traumatic Stress Disorder Case Studies
Figure 12. Others Case Studies
Figure 13. Mental Disorder Treatment Report Years Considered
Figure 14. Global Mental Disorder Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Mental Disorder Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Mental Disorder Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Mental Disorder Treatment Market Share by Players in 2023
Figure 18. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Mental Disorder Treatment Revenue in 2023
Figure 20. North America Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Mental Disorder Treatment Market Share by Country (2019-2030)
Figure 22. United States Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Mental Disorder Treatment Market Share by Country (2019-2030)
Figure 26. Germany Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Mental Disorder Treatment Market Share by Region (2019-2030)
Figure 34. China Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Mental Disorder Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Mental Disorder Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Mental Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Allergan Plc Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 50. VistaGen Therapeutics Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 51. Sanofi S.A Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 52. Novartis International AG Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 53. Mylan N.V Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 54. Amneal Pharmaceuticals LLC Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 55. Cipla Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 57. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 58. Lupin Limited Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 59. Janssen Pharmaceutica Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 61. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies